潤達醫療(603108.SH):預計2024年淨利潤同比減少81.16%到84.3%
格隆匯1月20日丨潤達醫療(603108.SH)公佈,經公司財務部門初步測算,預計2024年度實現歸屬母公司所有者的淨利潤為4,291萬元到5,149萬元,與上年同期相比,減少22,181萬元到23,039萬元,同比減少81.16%到84.30%。預計2024年度實現歸屬於母公司所有者的扣除非經常性損益的淨利潤為2,197萬元到2,636萬元,與上年同期相比,減少12,304萬元到12,743萬元,同比減少82.36%到85.29%。
本報吿期歸屬於上市公司股東的淨利潤較上年同期大幅減少主要是受公司主營業務影響:受國內宏觀環境及集中採購等醫療政策環境影響,公司業務發展受到影響,銷售收入不及預期,但公司服務成本、固定資產折舊等固定開支未減少,邊際成本費用增加,導致公司報吿期內淨利潤較上年同期減少。同時,終端客户的應收賬款回款週期延長,產生的信用減值損失對當期的歸母淨利潤也有較大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.